Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Beacon Therapeutics Raises $170M Series B

2024-07-03
CAMBRIDGE, MA, Beacon Therapeutics has raised $170M in Series B funding led by Forbion.
Beacon Therapeutics has raised $170M in Series B funding led by Forbion alongside existing investors Syncona and Oxford Science Enterprises, as well as new investors TCGX and Advent Life Sciences.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors